Semaphorin 3B (SEMA3B) induces apoptosis in lung and breast cancer, whereas VEGF165 antagonizes this effect

Proceedings of the National Academy of Sciences of the United States of America

Volumn 101, Issue 31, 2004, Pages 11432-11437

  Castro Rivera, Emely ^a   Ran, Sophia ^a,b,c   Thorpe, Philip ^a,b   Minna, John D ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIGAND; NEUROPILIN; NEUROPILIN 1; NEUROPILIN 2; SEMAPHORIN; SEMAPHORIN 3B; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN ANTIBODY; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANIMAL CELL; APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; BINDING COMPETITION; BREAST CANCER; CANCER INHIBITION; CELL SURVIVAL; CONTROLLED STUDY; DNA METHYLATION; GENE EXPRESSION; GENE INACTIVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG CANCER; MITOSIS INHIBITION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FAMILY; PROTEIN SECRETION; PROTEIN VARIANT; RECEPTOR BINDING; TUMOR SUPPRESSOR GENE;

ANIMALS; APOPTOSIS; BREAST NEOPLASMS; CELL DIVISION; CELL LINE, TUMOR; CELL SURVIVAL; COS CELLS; GENE EXPRESSION; IODINE RADIOISOTOPES; LUNG NEOPLASMS; MEMBRANE GLYCOPROTEINS; NEUROPILIN-1; NEUROPILIN-2; SEMAPHORINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

ANIMALIA;

EID: 3843113186     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0403969101     Document Type: Article

References (45)

1. Lerman, M. I. & Minna, J. D. (2000) Cancer Res. 60, 6116-6133.
2. Sekido, Y., Bader, S., Latif, F., Chen, J. Y., Duh, F. M., Wei, M. H., Albanesi, J. P., Lee, C. C., Lerman, M. I. & Minna, J. D. (1996) Proc. Natl. Acad. Sci. USA 93, 4120-4125.
3. Kuroki, T., Trapasso, F., Yendamuri, S., Matsuyama, A., Alder, H., Williams, N. N., Kaiser, L. R. & Croce, C. M. (2003) Cancer Res. 63, 3352-3355.
4. Tomizawa, Y., Sekido, Y., Kondo, M., Gao, B., Yokota, J., Roche, J., Drabkin, H., Lerman, M. I., Gazdar, A. F. & Minna, J. D. (2001) Proc. Natl. Acad. Sci. USA 98, 13954-13959.
5. Tse, C., Xiang, R. H., Bracht, T. & Naylor, S. L. (2002) Cancer Res. 62, 542-546.
6. Ochi, K., Mori, T., Toyama, Y., Nakamura, Y. & Arakawa, H. (2002) Neoplasia 4, 82-87.
7. Kolodkin, A. L., Matthes, D. J. & Goodman, C. S. (1993) Cell 75, 1389-1399.
8. Puschel, A. W. (1996) Eur. J. Neurosci. 8, 1317-1321.
9. Hall, K. T., Boumsell, L., Schultze, J. L., Boussiotis, V. A., Dorfman, D. M., Cardoso, A. A., Bensussan, A., Nadler, L. M. & Freeman, G. J. (1996) Proc. Natl. Acad. Sci. USA 93, 11780-11785.
10. Kumanogoh, A. & Kikutani, H. (2001) Trends Immunol. 22, 670-676.
11. Behar, O., Golden, J. A., Mashimo, H., Schoen, F. J. & Fishman, M. C. (1996) Nature 383, 525-528.
12. Gagliardini, V. & Fankhauser, C. (1999) Mol. Cell. Neurosci. 14, 301-316.
13. Yamada, T., Endo, R., Gotoh, M. & Hirohashi, S. (1997) Proc. Natl. Acad. Sci. USA 94, 14713-14718.
14. Tamagnone, L., Artigiani, S., Chen, H., He, Z., Ming, G. I., Song, H., Chedotal, A., Winberg, M. L., Goodman, C. S., Poo, M., et al. (1999) Cell 99, 71-80.
15. Takahashi, T., Fournier, A., Nakamura, F., Wang, L. H., Murakami, Y., Kalb, R. G., Fujisawa, H. & Strittmatter, S. M. (1999) Cell 99, 59-69.
16. Rohm, B., Ottemeyer, A., Lohrum, M. & Puschel, A. W. (2000) Mech. Dev. 93, 95-104.
17. Ohta, K., Mizutani, A., Kawakami, A., Murakami, Y., Kasuya, Y., Takagi, S., Tanaka, H. & Fujisawa, H. (1995) Neuron 14, 1189-1199.
18. Winberg, M. L., Noordermeer, J. N., Tamagnone, L., Comoglio, P. M., Spriggs, M. K., Tessier-Lavigne, M. & Goodman, C. S. (1998) Cell 95, 903-916.
19. Maestrini, E., Tamagnone, L., Longati, P., Cremona, O., Gulisano, M., Bione, S., Tamanini, F., Neel, B. G., Toniolo, D. & Comoglio, P. M. (1996) Proc. Natl. Acad. Sci. USA 93, 674-678.
20. Soker, S., Fidder, H., Neufeld, G. & Klagsbrun, M. (1996) J. Biol. Chem. 271, 5761-5767.
21. Soker, S., Takashima, S., Miao, H. Q., Neufeld, G. & Klagsbrun, M. (1998) Cell 92, 735-745.
22. Migdal, M., Huppertz, B., Tessler, S., Comforti, A., Shibuya, M., Reich, R., Baumann, H. & Neufeld, G. (1998) J. Biol. Chem. 273, 22272-22278.
23. Makinen, T., Olofsson, B., Karpanen, T., Hellman, U., Soker, S., Klagsbrun, M., Eriksson, U. & Alitalo, K. (1999) J. Biol. Chem. 274, 21217-21222.
24. Houck, K. A., Ferrara, N., Winer, J., Cachianes, G., Li, B. & Leung, D. W. (1991) Mol. Endocrinol. 5, 1806-1814.
25. Yamada, Y., Takakura, N., Yasue, H., Ogawa, H., Fujisawa, H. & Suda, T. (2001) Blood 97, 1671-1678.
26. Kitsukawa, T., Shimono, A., Kawakami, A., Kondoh, H. & Fujisawa, H. (1995) Development (Cambridge, U.K.) 121, 4309-4318.
27. Gu, C., Limberg, B. J., Whitaker, G. B., Perman, B., Leahy, D. J., Rosenbaum, J. S., Ginty, D. D. & Kolodkin, A. L. (2002) J. Biol. Chem. 277, 18069-18076.
28. Miao, H. Q., Soker, S., Feiner, L., Alonso, J. L., Raper, J. A. & Klagsbrun, M. (1999) J. Cell Biol. 146, 233-242.
29. Bagnard, D., Vaillant, C., Khuth, S. T., Dufay, N., Lohrum, M., Puschel, A. W., Belin, M. F., Bolz, J. & Thomasset, N. (2001) J. Neurosci. 21, 3332-3341.
30. Masood, R., Kundra, A., Zhu, S., Xia, G., Scalia, P., Smith, D. L. & Gill, P. S. (2003) Int. J. Cancer 104, 603-610.
31. Zhu, Z., Hattori, K., Zhang, H., Jimenez, X., Ludwig, D. L., Dias, S., Kussie, P., Koo, H., Kim, H. J., Lu, D., et al. (2003) Leukemia 17, 604-611.
32. Bachelder, R. E., Crago, A., Chung, J., Wendt, M. A., Shaw, L. M., Robinson, G. & Mercurio, A. M. (2001) Cancer Res. 61, 5736-5740.
33. Bachelder, R. E., Lipscomb, E. A., Lin, X., Wendt, M. A., Chadborn, N. H., Eickholt, B. J. & Mercurio, A. M. (2003) Cancer Res. 63, 5230-5233.
34. Waltenberger, J., Claesson-Welsh, L., Siegbahn, A., Shibuya, M. & Heldin, C. H. (1994) J. Biol. Chem. 269, 26988-26995.
35. Deroanne, C. F., Bonjean, K., Servotte, S., Devy, L., Colige, A., Clausse, N., Blacher, S., Verdin, E., Foidart, J. M., Nusgens, B. V. & Castronovo, V. (2002) Oncogene 21, 427-436.
36. Nakamura, F., Tanaka, M., Takahashi, T., Kalb, R. G. & Strittmatter, S. M. (1998) Neuron 21, 1093-1100.
37. Brekken, R. A., Overholser, J. P., Stastny, V. A., Waltenberger, J., Minna, J. D. & Thorpe, P. E. (2000) Cancer Res. 60, 5117-5124.
38. Shirvan, A., Shina, R., Ziv, I., Melamed, E. & Barzilai, A. (2000) Brain Res. Mol. Brain Res. 83, 81-93.
39. Shirvan, A., Ziv, I., Fleminger, G., Shina, R., He, Z., Brudo, I., Melamed, E. & Barzilai, A. (1999) J. Neurochem. 73, 961-971.
40. Nasarre, P., Constantin, B., Rouhaud, L., Harnois, T., Raymond, G., Drabkin, H. A., Bourmeyster, N. & Roche, J. (2003) Neoplasia 5, 83-92.
41. Cassano, A., Bagala, C., Battelli, C., Schinzari, G., Quirino, M., Ratto, C., Landriscina, M. & Barone, C. (2002) Anticancer Res. 22, 2179-2184.
42. Mamluk, R., Gechtman, Z., Kutcher, M. E., Gasiunas, N., Gallagher, J. & Klagsbrun, M. (2002) J. Biol. Chem. 277, 24818-24825.
43. Igarashi, H., Esumi, M., Ishida, H. & Okada, K. (2002) Cancer 95, 47-53.
44. Padro, T., Bieker, R., Ruiz, S., Steins, M., Retzlaff, S., Burger, H., Buchner, T., Kessler, T., Herrera, F., Kienast, J., et al. (2002) Leukemia 16, 1302-1310.
45. Mineta, H., Miura, K., Ogino, T., Takebayashi, S., Misawa, K. & Ueda, Y. (2002) Anticancer Res. 22, 1039-1044.